PARP2 and neoplasm: This transformation is not dependent on PARP1 or PARP2 but is the result of the accumulation of the PARP substrate NAD+, which allows for increased mitochondrial RET, resulting in ROS production and reprogramming toward an anti-tumor phenotype.